Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2003
03/26/2003CN1406248A Antibody for de tecting chlamydia pheumoniae
03/26/2003CN1406243A Memno peptides, a process for their preparation and their use
03/26/2003CN1405319A Method for producing human or animal metallothionein product using liquid submerged fermented transgenic engineered bacteria
03/26/2003CN1405182A 血清白蛋白与粒细胞集落刺激因子的融合蛋白 Serum albumin and granulocyte colony-stimulating factor fusion protein
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1404860A Chinese medicine multienzyme emulsifying method
03/26/2003CN1103820C Method for detection of methylthioadenosine phosphorylase deticiency in mammallian cells
03/26/2003CN1103812C Human beta-2 integrin alpha subunit
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103602C Process for preparing pharmaceutical formulation containing insulin analog
03/25/2003US6538127 Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538124 Polypeptide variants
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538118 Expression of lipoproteins
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma
03/25/2003US6538109 Polynucleotide compositions encoding broad spectrum delta-endotoxins
03/25/2003US6538108 Compositions and methods relating to DNA mismatch repair genes
03/25/2003US6537965 Novel parathyroid hormone (PTH) peptide derivatives. In particular, the invention relates to PTH PTH-2 receptor agonist or antagonist properties to the derivatives.
03/25/2003US6537815 Method of altering the expression of csrB to modify the properties of a cell
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537803 Produced by a recombinant expression vector in a cell; use in pharmacology and drug screening
03/25/2003US6537794 Chemokine
03/25/2003US6537782 Comprising enzymatic degradation product of fish meat or a fish meat extract; not containing mammal-derived components
03/25/2003US6537779 T7 promoter-based expression system
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537597 Process for producing soybean protein hydrolysate
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537552 Vaccine adjuvant
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537519 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2173957C Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/25/2003CA2056102C Method for the production of antibodies
03/20/2003WO2003023408A1 Compositions and methods for aa4rp assay
03/20/2003WO2003023405A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023039A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells
03/20/2003WO2003023030A2 Aminopeptidase
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023010A2 Sensory neuron receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022996A2 Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022879A2 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
03/20/2003WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof
03/20/2003WO2003022868A2 Metal binding proteins and associated methods
03/20/2003WO2003022225A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003WO2003022126A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002099067A3 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
03/20/2003WO2002088340A3 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002064811A3 Method for producing recombinant proteins marked with at least one isotope
03/20/2003WO2002061047A3 Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
03/20/2003WO2002058635A3 Nicotine immunogens and antibodies and uses thereof
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002053582A3 Process for producing peptides by using in vitrotranscription/translation system
03/20/2003WO2002046417A3 Adipocyte complement related protein zacrp3x2
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002026961A3 Production process of surfactin
03/20/2003WO2002022667A9 Twin-arginine translocation in bacillus
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002004520A3 Transporters and ion channels
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2002002591A3 Peptides for use in culture media
03/20/2003US20030056241 Chicken leukemia inhibitory factor (LIF) and gene thereof
03/20/2003US20030056229 Nucleotide sequences coding polypeptide for use in the treatment of leukemias, autoimmune and arthritic diseases
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055223 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
03/20/2003US20030055222 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030055218 Human receptor proteins; related reagents and methods
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055216 Nucleotide sequences coding polypeptide for use in the treatment of tumors
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054993 For contraception in a mammal, for therapy of infertility
03/20/2003US20030054992 Therapy
03/20/2003US20030054987 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
1 ... 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 ... 1125